Sandoz

Sandoz shells out $275M in latest effort to move past 'legacy' price-fixing litigation
Fierce Pharma
Tue, 12/17/24 - 12:03 pm
Sandoz
price fixing
legal
Sandoz, Liquidia score $137M win against United in years-long generic Remodulin dispute
Fierce Pharma
Mon, 09/16/24 - 10:22 pm
Sandoz
United Therapeutics
generics
PAH
Treprostinil
As Sandoz contract winds down, GSK will close antibiotics plant in UK
Fierce Pharma
Mon, 09/9/24 - 07:18 pm
GSK
Sandoz
UK
drug manufacturing
Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth
Fierce Pharma
Fri, 08/9/24 - 11:25 am
Sandoz
earnings
biosimilars
Humira
AbbVie
Novartis
Sandoz delivers 6% sales growth with Humira biosimilar leading the charge
Fierce Pharma
Tue, 05/7/24 - 06:30 pm
Sandoz
earnings
biosimilars
AbbVie
Humira
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes
Thu, 05/2/24 - 11:34 am
CVS Caremark
AbbVie
Humira
biosimilars
Hyrimoz
Sandoz
PBMs
Sandoz Nabs FDA Approvals for First Two Biosimilars for Amgen’s Denosumab
BioSpace
Wed, 03/6/24 - 11:29 am
Sandoz
biosimilars
FDA
Amgen
denosumab
Prolia
Jubbonti
Xgeva
Wyost
Sandoz completes acquisition of ranibizumab biosimilar
Healio
Mon, 03/4/24 - 11:52 pm
Sandoz
ranibizumab
Coherus Biosciences
Cimerli
Sandoz will pay $265m to settle price fixing case in US
Pharmaphorum
Thu, 02/29/24 - 09:44 am
Sandoz
price fixing
legal
Pennsylvania
Amid tough generics market, Sandoz to lay off 213 and shutter Eon Labs plant in North Carolina
Fierce Pharma
Thu, 02/8/24 - 09:57 pm
Sandoz
layoffs
North Carolina
generics
drug manufacturing
Sandoz makes its first post-spinout acquisition
Pharmaphorum
Mon, 01/22/24 - 11:12 am
Sandoz
M&A
Coherus
biosimilars
AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players
Fierce Pharma
Wed, 11/22/23 - 11:39 am
AbbVie
Rinvoq
patents
legal
Sandoz
Sun Pharma
Intas Pharmaceuticals
Novartis' Sandoz dips on debut after lower than expected valuation
Reuters
Wed, 10/4/23 - 09:43 am
Novartis
Sandoz
spinoffs
Novartis confirms Sandoz spin-off for October 4, 2023
Reuters
Mon, 09/25/23 - 07:45 pm
Novartis
Sandoz
spinoffs
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
BioSpace
Tue, 09/12/23 - 10:40 am
Sandoz
Samsung Bioepis
biosimilars
JNJ
Stelara
Novartis updates on Sandoz finances ahead of spin-off
Pharmaphorum
Tue, 09/5/23 - 11:18 am
Novartis
Sandoz
spinoffs
generics
biosimilars
FDA Decisions 2023: Sandoz, Gilead Sciences and More
BioSpace
Fri, 08/25/23 - 11:31 am
FDA
Sandoz
Novartis
Gilead Sciences
Pfizer
Neurocrine
Regeneron
Ipsen
Revance Therapeutics
Delcath Systems
Janssen
Galera Therapeutics
Biogen
Roche
Mesoblast
Taiho Oncology
FDA Approves Sandoz Biosimilar to Biogen’s MS Therapy Tysabri
BioSpace
Fri, 08/25/23 - 09:53 am
Biogen
Sandoz
FDA
biosimilars
MS
multiple sclerosis
Tysabri
Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation
Biopharma Reporter
Mon, 08/21/23 - 06:50 pm
Novartis
Sandoz
spinoff
biosimilars
generics
Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4
Fierce Pharma
Fri, 08/18/23 - 11:29 am
Novartis
Sandoz
spinoffs
generics
biosimilars

Pages